All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 2012-12-10? to Tue 2025-07-15 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
VOO × |
+4.41%
2025-07-15 |
5.036 TRR
2025-07-15 |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × |
+5.35%
2025-07-15 |
6.329 TRR
2025-07-15 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Tue 2025-07-15 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
VOO × |
+293.63%
+11.49%/yr |
+9.99%/yr
(R2=0.950) |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × |
+532.90%
+15.78%/yr |
+14.31%/yr
(R2=0.942) |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Tue 2025-07-15 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
VOO × |
$10,000.00
2012-12-10 |
$39,362.61
2025-07-15 |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × |
$10,000.00
2012-12-10 |
$63,290.32
2025-07-15 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Year | VOO | ABBV |
---|---|---|
2025 (YTD) | +4.41% | +5.35% |
2024 | +21.48% | +15.53% |
2023 | +22.23% | −3.47% |
2022 | −23.14% | +16.48% |
2021 | +20.33% | +23.72% |
2020 | +16.73% | +26.00% |
2019 | +28.43% | −0.79% |
2018 | −6.29% | −2.81% |
2017 | +19.25% | +56.75% |
2016 | +9.89% | +7.57% |
2015 | +0.59% | −7.18% |
2014 | +12.71% | +26.97% |
2013 | +30.42% | +58.39% |
2012 | +14.02% | −2.24% |
2011 | −1.04% | — |
2010 | +14.34% | — |
Mon 2012-12-10? to Tue 2025-07-15 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
VOO × | −0.67% |
−33.95%
2020-03-23 |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × | −13.40% |
−47.00%
2019-08-15 |
||||
AbbVie Inc NYSE Common Stock | ||||||